Affiliation:
1. Antimicrobial Resistance Unit
2. Antimicrobial Agents Research Group, School of Immunity and Infection, University of Birmingham, Birmingham B15 2TT, United Kingdom
3. Department of Medicine, Turku University Hospital and University of Turku, Turku, Finland
4. Gastrointestinal Infection Unit, National Institute for Health and Welfare, Turku and Helsinki, Finland
Abstract
ABSTRACT
Nontyphoidal
Salmonella enterica
strains with a nonclassical quinolone resistance phenotype were isolated from patients returning from Thailand or Malaysia to Finland. A total of 10 isolates of seven serovars were studied in detail, all of which had reduced susceptibility (MIC ≥ 0.125 μg/ml) to ciprofloxacin but were either susceptible or showed only low-level resistance (MIC ≤ 32 μg/ml) to nalidixic acid. Phenotypic characterization included susceptibility testing by the agar dilution method and investigation of efflux activity. Genotypic characterization included the screening of mutations in the quinolone resistance-determining regions (QRDR) of
gyrA
,
gyrB
,
parC
, and
parE
by PCR and denaturing high-pressure liquid chromatography and the amplification of plasmid-mediated quinolone resistance (PMQR) genes
qnrA
,
qnrB
,
qnrS
,
qnrD
,
aac(6
′
)-Ib-cr
, and
qepA
by PCR. PMQR was confirmed by plasmid analysis, Southern hybridization, and plasmid transfer. No mutations in the QRDRs of
gyrA
,
gyrB
,
parC
, or
parE
were detected with the exception of a Thr57-Ser substitution within ParC seen in all but the
S. enterica
serovar Typhimurium strains. The
qnrA
and
qnrS
genes were the only PMQR determinants detected. Plasmids carrying
qnr
alleles were transferable in vitro, and the resistance phenotype was reproducible in
Escherichia coli
DH5α transformants. These data demonstrate the emergence of a highly mobile
qnr
genotype that, in the absence of mutation within topoisomerase genes, confers the nontypical quinolone resistance phenotype in
S. enterica
isolates. The
qnr
resistance mechanism enables bacteria to survive elevated quinolone concentrations, and therefore, strains carrying
qnr
alleles may be able to expand during fluoroquinolone treatment. This is of concern since nonclassical quinolone resistance is plasmid mediated and therefore mobilizable.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology